• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Bringing Multi-Cancer Tests Closer to Reality

Bringing Multi-Cancer Tests Closer to Reality

by Rachel Muenz | Feb 21, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

A new method for early detection of 14 cancer types based on glycosaminoglycan profiles shows promise.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
A Better Test for Early Detection of Multiple Cancers?

A Better Test for Early Detection of Multiple Cancers?

by Rachel Muenz | Feb 7, 2023 | News, Open Content

A new method of early, multi-cancer detection could prove more effective for non-invasive screening than other emerging options.

Easier, Noninvasive Diagnosis of Neurological Disorders

by Glenn S. Demby | Jan 26, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Improving the Chances of Early Breast Cancer Detection in High-Risk Patients

by Glenn S. Demby | Dec 21, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Urine Test Can Detect Synthetic Cannabinoids in Marijuana

New Urine Test Can Detect Synthetic Cannabinoids in Marijuana

by Glenn S. Demby | Nov 21, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com